F Halimi1, P Sabouret2, J P Huberman3, L Ouazana3, D Guedj3, K Djouadi4, T S Dhanjal5, A Goette6, C Lafont7,8, Nicolas Lellouche9. 1. Hôpital Privé, Parly 2, 21 rue Moxouris, 78150, Le Chesnay, France. 2. Department of Cardiology, AP-HP, University Hospital Pitié-Salpétrière, Creteil, France. 3. French College of Cardiology, 75014, Paris, France. 4. Department of Cardiology, AP-HP, University Hospital Henri Mondor, 51, Avenue du Maréchal de Lattre de Tassigny, 94000, Creteil, France. 5. Department of Cardiac Electrophysiology, University of Warwick, Gibbet Hill, Coventry, UK. 6. Department of Cardiac Electrophysiology, St Vincenz Kliniken, Paderborn, Germany. 7. Univ Paris Est Creteil, INSERM, IMRB, 94010, Creteil, France. 8. Service de Santé Publique, AP-HP, Hôpital Henri-Mondor, 94010, Créteil, France. 9. Department of Cardiology, AP-HP, University Hospital Henri Mondor, 51, Avenue du Maréchal de Lattre de Tassigny, 94000, Creteil, France. nicolellouche@yahoo.com.
Abstract
AIM: New technologic tools for continuous ECG monitoring have been developed to detect and treat atrial fibrillation (AF) in specific populations with high cardiovascular risk. We evaluated the prevalence and the management of AF diagnosed in patients with high cardiovascular risk and non-documented clinical palpitation undergoing systematic 14-day continuous ECG-Holter monitoring. METHODS: Patients were prospectively enrolled from December 2019 to December 2021 in this multicentre study, sponsored by the French National College of Cardiology. Patients met the following criteria: CHA2DS2VASc score ≥ 2 in males and ≥ 3 in females and clinical palpitations without previously documented arrhythmia. Enrolled patients underwent a continuous 14-day Holter-ECG monitoring for arrhythmia detection. RESULTS: Among the 336 included patients, 39% were male, 75% were greater than 65 years of age and 46.5% had suffered a prior stroke. AF was detected in 14% of patients, among which 23.4% were detected in the first 24 h of monitoring. Finally, age ≥ 65 years (p = 0.037) was significantly associated with AF, as well as male gender (p = 0.023) and a lower rate of antiplatelet therapy (p = 0.018). Patients with diagnosed AF had a prescription of anticoagulation therapy in 90%. Antiarrhythmic drugs were administered in 90% of AF patients and 13% underwent AF ablation. CONCLUSIONS: The systematic AF screening of patients with palpitations and high cardiovascular risk resulted in a diagnostic yield of AF in 14% of the population with a 14-day continuous ECG-Holter monitor. This strategy resulted in the prescription of anticoagulation and antiarrhythmic therapy in 90% of the AF detected population.
AIM: New technologic tools for continuous ECG monitoring have been developed to detect and treat atrial fibrillation (AF) in specific populations with high cardiovascular risk. We evaluated the prevalence and the management of AF diagnosed in patients with high cardiovascular risk and non-documented clinical palpitation undergoing systematic 14-day continuous ECG-Holter monitoring. METHODS: Patients were prospectively enrolled from December 2019 to December 2021 in this multicentre study, sponsored by the French National College of Cardiology. Patients met the following criteria: CHA2DS2VASc score ≥ 2 in males and ≥ 3 in females and clinical palpitations without previously documented arrhythmia. Enrolled patients underwent a continuous 14-day Holter-ECG monitoring for arrhythmia detection. RESULTS: Among the 336 included patients, 39% were male, 75% were greater than 65 years of age and 46.5% had suffered a prior stroke. AF was detected in 14% of patients, among which 23.4% were detected in the first 24 h of monitoring. Finally, age ≥ 65 years (p = 0.037) was significantly associated with AF, as well as male gender (p = 0.023) and a lower rate of antiplatelet therapy (p = 0.018). Patients with diagnosed AF had a prescription of anticoagulation therapy in 90%. Antiarrhythmic drugs were administered in 90% of AF patients and 13% underwent AF ablation. CONCLUSIONS: The systematic AF screening of patients with palpitations and high cardiovascular risk resulted in a diagnostic yield of AF in 14% of the population with a 14-day continuous ECG-Holter monitor. This strategy resulted in the prescription of anticoagulation and antiarrhythmic therapy in 90% of the AF detected population.
Authors: Bouwe P Krijthe; Anton Kunst; Emelia J Benjamin; Gregory Y H Lip; Oscar H Franco; Albert Hofman; Jacqueline C M Witteman; Bruno H Stricker; Jan Heeringa Journal: Eur Heart J Date: 2013-07-30 Impact factor: 29.983
Authors: Jeff S Healey; Stuart J Connolly; Michael R Gold; Carsten W Israel; Isabelle C Van Gelder; Alessandro Capucci; C P Lau; Eric Fain; Sean Yang; Christophe Bailleul; Carlos A Morillo; Mark Carlson; Ellison Themeles; Elizabeth S Kaufman; Stefan H Hohnloser Journal: N Engl J Med Date: 2012-01-12 Impact factor: 91.245
Authors: Michael Glikson; Jens Cosedis Nielsen; Mads Brix Kronborg; Yoav Michowitz; Angelo Auricchio; Israel Moshe Barbash; José A Barrabés; Giuseppe Boriani; Frieder Braunschweig; Michele Brignole; Haran Burri; Andrew J S Coats; Jean-Claude Deharo; Victoria Delgado; Gerhard-Paul Diller; Carsten W Israel; Andre Keren; Reinoud E Knops; Dipak Kotecha; Christophe Leclercq; Béla Merkely; Christoph Starck; Ingela Thylén; José Maria Tolosana; Francisco Leyva; Cecilia Linde; Magdy Abdelhamid; Victor Aboyans; Elena Arbelo; Riccardo Asteggiano; Gonzalo Barón-Esquivias; Johann Bauersachs; Mauro Biffi; Ulrika Birgersdotter-Green; Maria Grazia Bongiorni; Michael A Borger; Jelena Čelutkienė; Maja Cikes; Jean-Claude Daubert; Inga Drossart; Kenneth Ellenbogen; Perry M Elliott; Larissa Fabritz; Volkmar Falk; Laurent Fauchier; Francisco Fernández-Avilés; Dan Foldager; Fredrik Gadler; Pastora Gallego Garcia De Vinuesa; Bulent Gorenek; Jose M Guerra; Kristina Hermann Haugaa; Jeroen Hendriks; Thomas Kahan; Hugo A Katus; Aleksandra Konradi; Konstantinos C Koskinas; Hannah Law; Basil S Lewis; Nicholas John Linker; Maja-Lisa Løchen; Joost Lumens; Julia Mascherbauer; Wilfried Mullens; Klaudia Vivien Nagy; Eva Prescott; Pekka Raatikainen; Amina Rakisheva; Tobias Reichlin; Renato Pietro Ricci; Evgeny Shlyakhto; Marta Sitges; Miguel Sousa-Uva; Richard Sutton; Piotr Suwalski; Jesper Hastrup Svendsen; Rhian M Touyz; Isabelle C Van Gelder; Kevin Vernooy; Johannes Waltenberger; Zachary Whinnett; Klaus K Witte Journal: Europace Date: 2022-01-04 Impact factor: 5.214
Authors: Tommaso Sanna; Hans-Christoph Diener; Rod S Passman; Vincenzo Di Lazzaro; Richard A Bernstein; Carlos A Morillo; Marilyn Mollman Rymer; Vincent Thijs; Tyson Rogers; Frank Beckers; Kate Lindborg; Johannes Brachmann Journal: N Engl J Med Date: 2014-06-26 Impact factor: 91.245
Authors: Taya V Glotzer; Emile G Daoud; D George Wyse; Daniel E Singer; Michael D Ezekowitz; Christopher Hilker; Clayton Miller; Dongfeng Qi; Paul D Ziegler Journal: Circ Arrhythm Electrophysiol Date: 2009-08-04
Authors: Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins Journal: Eur Heart J Date: 2021-02-01 Impact factor: 29.983
Authors: Marco V Perez; Kenneth W Mahaffey; Haley Hedlin; John S Rumsfeld; Ariadna Garcia; Todd Ferris; Vidhya Balasubramanian; Andrea M Russo; Amol Rajmane; Lauren Cheung; Grace Hung; Justin Lee; Peter Kowey; Nisha Talati; Divya Nag; Santosh E Gummidipundi; Alexis Beatty; Mellanie True Hills; Sumbul Desai; Christopher B Granger; Manisha Desai; Mintu P Turakhia Journal: N Engl J Med Date: 2019-11-14 Impact factor: 176.079